Cytokinetics, Incorporated (CYTK) Insider Trading

Over the last 3 months, CYTK insiders made 0 open-market buys and 18 sales, a net sale of -$11.9M (SEC Form 4). Over the last 6 months, 423 institutions increased and 249 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
18
Net (3m)
-$11.9M
Insider trades by month Buys Sells
Apr
May
Jun
Jul
Aug
Sep
Context3-month price -0.2%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Sep 1, 2026PARSHALL B LYNNEdirectorSell5,000$71.48
Aug 31, 2026Callos Andrewofficer: EVP, Chief Commercial OfficerSell10,000$70.24
Aug 31, 2026Callos Andrewofficer: EVP, Chief Commercial OfficerOption10,000$23.26
Aug 31, 2026Blum Robert Idirector, officer: President & CEOSell7,500$70.24
Aug 31, 2026Blum Robert Idirector, officer: President & CEOOption7,500$10.60
Aug 18, 2026Malik Fady Ibrahamofficer: EVP Research & DevelopmentSell3,500$75.82
Aug 18, 2026Malik Fady Ibrahamofficer: EVP Research & DevelopmentOption3,500$7.80
Aug 10, 2026Blum Robert Idirector, officer: President & CEOOption7,500$10.60
Aug 10, 2026Blum Robert Idirector, officer: President & CEOSell7,500$76.76
Jul 30, 2026Callos Andrewofficer: EVP, Chief Commercial OfficerOption14,000$23.26
Jul 30, 2026Callos Andrewofficer: EVP, Chief Commercial OfficerSell14,000$79.88
Jul 27, 2026Blum Robert Idirector, officer: President & CEOSell7,500$80.87
Jul 27, 2026Blum Robert Idirector, officer: President & CEOOption7,500$10.60
Jul 23, 2026Malik Fady Ibrahamofficer: EVP Research & DevelopmentOption3,500$7.80
Jul 23, 2026Malik Fady Ibrahamofficer: EVP Research & DevelopmentSell3,500$80.59
Jul 16, 2026WIERENGA WENDELLdirectorGrant75$82.62
Jul 16, 2026Harrington Robert ArthurdirectorGrant151$82.62
Jul 16, 2026Kaye Edward M. MDdirectorGrant151$82.62
Jul 16, 2026Daly James MdirectorGrant151$82.62
Jul 16, 2026HENDERSON JOHN TdirectorGrant272$82.62
Jul 16, 2026Wysenski NancydirectorGrant75$82.62
Jul 14, 2026Blum Robert Idirector, officer: President & CEOOption7,490$10.60
Jul 14, 2026Blum Robert Idirector, officer: President & CEOSell7,490$82.02
Jul 7, 2026Malik Fady Ibrahamofficer: EVP Research & DevelopmentOption3,500$7.80
Jul 7, 2026Malik Fady Ibrahamofficer: EVP Research & DevelopmentSell3,500$86.62
Jul 2, 2026Lee Sungofficer: EVP, Chief Financial OfficerSell1,112$87.79
Jul 2, 2026Blum Robert Idirector, officer: President & CEOSell7,500$84.92
Jul 2, 2026Callos Andrewofficer: EVP, Chief Commercial OfficerOption15,000$23.26
Jul 2, 2026Callos Andrewofficer: EVP, Chief Commercial OfficerSell15,000$85.80
Jul 2, 2026Lee Sungofficer: EVP, Chief Financial OfficerOption1,112$48.51

Source: CYTK SEC Form 4 filings, latest Sep 1, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their CYTK positions over the last 6 months (SEC Form 13F).

Increased
423
New positions
174
Reduced
249
Sold out
53
Largest moves
InstitutionActionSharesFiled
BlackRock, Inc.Increased20.1MAug 7, 2026
T. Rowe Price Investment Management, Inc.Increased18.7MAug 14, 2026
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.Reduced17.5MMay 15, 2026
BLACKROCK, INC.Increased16.5MMay 13, 2026
FMR LLCReduced10.7MMay 15, 2026
WELLINGTON MANAGEMENT GROUP LLPIncreased8.0MMay 15, 2026
WELLINGTON MANAGEMENT GROUP LLPReduced6.9MAug 14, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCIncreased6.7MAug 13, 2026
STATE STREET CORPIncreased6.5MAug 7, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased6.1MAug 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position5.8MMay 8, 2026
STATE STREET CORPReduced5.7MMay 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position5.5MMay 15, 2026
FMR LLCReduced5.0MAug 13, 2026
Avoro Capital Advisors LLCIncreased5.0MAug 14, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.